Effect of antibodies against intercellular adhesion molecule-1, B7, and CD40 on interleukin-18-treated human mixed lymphocyte reaction.
Effect of antibodies against intercellular adhesion molecule-1, B7, and CD40 on interleukin-18-treated human mixed lymphocyte reaction.
复制标题
DOI:
10.1254/jphs.sc0040167
复制
发表时间:
2005
影响因子:
3.5
通讯作者:
Hideo Takahashi;H. Iwagaki;R. Tamura;T. Yagi;T. Yoshino;S. Mori;N. Tanaka;M. Nishibori
中科院分区:
文献类型:
--
作者:
Hideo Takahashi;H. Iwagaki;R. Tamura;T. Yagi;T. Yoshino;S. Mori;N. Tanaka;M. Nishibori
The interleukin (IL)-18 level in plasma is elevated during the acute rejection after organ transplantation. IL-18 elicits adhesion molecule expression as well as interferon-gamma/IL-12 production and T-cell proliferation in the human mixed lymphocyte reaction, an in vitro model of acute rejection. We examined whether antibodies (Abs) against intercellular adhesion molecule (ICAM)-1, B7, CD40, and CD40, ligand (CD40L) affect the cytokine production and T-cell proliferation. Anti-ICAM-1 and B7 Abs suppressed the cytokine production, while all Abs inhibited T-cell proliferation. ICAM-1 and B7 as well as CD40 may play different roles in the acute rejection.